265 related articles for article (PubMed ID: 31805309)
1. Characterization of doxorubicin liposomal formulations for size-based distribution of drug and excipients using asymmetric-flow field-flow fractionation (AF4) and liquid chromatography-mass spectrometry (LC-MS).
Ansar SM; Mudalige T
Int J Pharm; 2020 Jan; 574():118906. PubMed ID: 31805309
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of size-based distribution of drug and excipient in amphotericin B liposomal formulation.
Van Haute D; Jiang W; Mudalige T
Int J Pharm; 2019 Oct; 569():118603. PubMed ID: 31401296
[TBL] [Abstract][Full Text] [Related]
3. Asymmetrical flow field-flow fractionation for improved characterization of human plasma lipoproteins.
Bria CRM; Afshinnia F; Skelly PW; Rajendiran TM; Kayampilly P; Thomas TP; Andreev VP; Pennathur S; Kim Ratanathanawongs Williams S
Anal Bioanal Chem; 2019 Jan; 411(3):777-786. PubMed ID: 30470915
[TBL] [Abstract][Full Text] [Related]
4. Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations.
Luo R; Li Y; He M; Zhang H; Yuan H; Johnson M; Palmisano M; Zhou S; Sun D
Int J Pharm; 2017 Mar; 519(1-2):1-10. PubMed ID: 28063903
[TBL] [Abstract][Full Text] [Related]
5. Core lipid, surface lipid and apolipoprotein composition analysis of lipoprotein particles as a function of particle size in one workflow integrating asymmetric flow field-flow fractionation and liquid chromatography-tandem mass spectrometry.
Kuklenyik Z; Jones JI; Gardner MS; Schieltz DM; Parks BA; Toth CA; Rees JC; Andrews ML; Carter K; Lehtikoski AK; McWilliams LG; Williamson YM; Bierbaum KP; Pirkle JL; Barr JR
PLoS One; 2018; 13(4):e0194797. PubMed ID: 29634782
[TBL] [Abstract][Full Text] [Related]
6. Determination of non-liposomal and liposomal doxorubicin in plasma by LC-MS/MS coupled with an effective solid phase extraction: In comparison with ultrafiltration technique and application to a pharmacokinetic study.
Xie Y; Shao N; Jin Y; Zhang L; Jiang H; Xiong N; Su F; Xu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():149-160. PubMed ID: 29175695
[TBL] [Abstract][Full Text] [Related]
7. A simple and rapid measurement method of encapsulation efficiency of doxorubicin loaded liposomes by direct injection of the liposomal suspension to liquid chromatography.
Yamamoto E; Miyazaki S; Aoyama C; Kato M
Int J Pharm; 2018 Jan; 536(1):21-28. PubMed ID: 29175642
[TBL] [Abstract][Full Text] [Related]
8. Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles.
Caputo F; Arnould A; Bacia M; Ling WL; Rustique E; Texier I; Mello AP; Couffin AC
Mol Pharm; 2019 Feb; 16(2):756-767. PubMed ID: 30604620
[TBL] [Abstract][Full Text] [Related]
9. Human Biomolecular Corona of Liposomal Doxorubicin: The Overlooked Factor in Anticancer Drug Delivery.
Caracciolo G; Palchetti S; Digiacomo L; Chiozzi RZZ; Capriotti AL; Amenitsch H; Tentori PM; Palmieri V; Papi M; Cardarelli F; Pozzi D; Laganà A
ACS Appl Mater Interfaces; 2018 Jul; 10(27):22951-22962. PubMed ID: 29905462
[TBL] [Abstract][Full Text] [Related]
10. Practical aspects in size and morphology characterization of drug-loaded nano-liposomes.
Peretz Damari S; Shamrakov D; Varenik M; Koren E; Nativ-Roth E; Barenholz Y; Regev O
Int J Pharm; 2018 Aug; 547(1-2):648-655. PubMed ID: 29913218
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric flow field flow fractionation of aqueous C60 nanoparticles with size determination by dynamic light scattering and quantification by liquid chromatography atmospheric pressure photo-ionization mass spectrometry.
Isaacson CW; Bouchard D
J Chromatogr A; 2010 Feb; 1217(9):1506-12. PubMed ID: 20070969
[TBL] [Abstract][Full Text] [Related]
12. Development of a Flow-Through USP-4 Apparatus Drug Release Assay to Evaluate Doxorubicin Liposomes.
Yuan W; Kuai R; Dai Z; Yuan Y; Zheng N; Jiang W; Noble C; Hayes M; Szoka FC; Schwendeman A
AAPS J; 2017 Jan; 19(1):150-160. PubMed ID: 27485642
[TBL] [Abstract][Full Text] [Related]
13. Direct and simultaneous determination of intra-liposomal and external sulfate in liposomal doxorubicin formulations by capillary electrophoresis/inductively coupled plasma-tandem mass spectrometry (CE/ICP-MS/MS).
Ansar SM; Mudalige T
Int J Pharm; 2019 Apr; 561():283-288. PubMed ID: 30844422
[TBL] [Abstract][Full Text] [Related]
14. Separation and characterization of liposomes using asymmetric flow field-flow fractionation with online multi-angle light scattering detection.
Écija-Arenas Á; Román-Pizarro V; Fernández-Romero JM
J Chromatogr A; 2021 Jan; 1636():461798. PubMed ID: 33341435
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric flow field flow fractionation for the characterization of globule size distribution in complex formulations: A cyclosporine ophthalmic emulsion case.
Qu H; Wang J; Wu Y; Zheng J; Krishnaiah YSR; Absar M; Choi S; Ashraf M; Cruz CN; Xu X
Int J Pharm; 2018 Mar; 538(1-2):215-222. PubMed ID: 29341918
[TBL] [Abstract][Full Text] [Related]
16. Combining gas-phase electrophoretic mobility molecular analysis (GEMMA), light scattering, field flow fractionation and cryo electron microscopy in a multidimensional approach to characterize liposomal carrier vesicles.
Urey C; Weiss VU; Gondikas A; von der Kammer F; Hofmann T; Marchetti-Deschmann M; Allmaier G; Marko-Varga G; Andersson R
Int J Pharm; 2016 Nov; 513(1-2):309-318. PubMed ID: 27639623
[TBL] [Abstract][Full Text] [Related]
17. Advanced analysis of polymer emulsions: Particle size and particle size distribution by field-flow fractionation and dynamic light scattering.
Makan AC; Spallek MJ; du Toit M; Klein T; Pasch H
J Chromatogr A; 2016 Apr; 1442():94-106. PubMed ID: 26987415
[TBL] [Abstract][Full Text] [Related]
18. Liposomal Doxorubicin Delivery Systems: Effects of Formulation and Processing Parameters on Drug Loading and Release Behavior.
Mohammadi ZA; Aghamiri SF; Zarrabi A; Talaie MR
Curr Drug Deliv; 2016; 13(7):1065-1070. PubMed ID: 26708673
[TBL] [Abstract][Full Text] [Related]
19. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
[TBL] [Abstract][Full Text] [Related]
20. Interaction of liposomes with bile salts investigated by asymmetric flow field-flow fractionation (AF4): A novel approach for stability assessment of oral drug carriers.
Bohsen MS; Tychsen ST; Kadhim AAH; Grohganz H; Treusch AH; Brandl M
Eur J Pharm Sci; 2023 Mar; 182():106384. PubMed ID: 36642346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
